Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Recenti Progressi in Medicina|March 14, 2025
[CAR-T cell therapy in a patient with relapsed/refractory mantle cell lymphoma.]Virginia Naso, Filippo Canale, Giorgia Policastro, et al.
International Journal of Molecular Sciences|January 21, 2023
Do CAR-T and Allogeneic Stem Cell Transplant Both Have a Place in Lymphoid Neoplasms?Massimo Martino, Filippo Antonio Canale, Virginia Naso, et al.
European Journal of Haematology|May 23, 2013
Very long-lasting remission of refractory T-large granular lymphocytes leukemia and myeloma by lenalidomide treatmentSabrina Pelliccia, Arianna Di Napoli, Virginia Naso, et al.
Expert Review of Hematology|June 29, 2019
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trialsMassimo Martino, Marco Rossi, Anna Ferreri, et al.
Hematology Reports|June 25, 2026
Quality of Life in CAR-T Cell TherapyCaterina Alati, Martina Pitea, Gaetana Porto, et al.
International Journal of Molecular Sciences|November 11, 2022
Chimeric Antigen Receptor T-Cell Therapy: What We Expect SoonMassimo Martino, Virginia Naso, Barbara Loteta, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 30, 2020
Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safetyMassimo Martino, Virginia Naso, Gaetana Porto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 25, 2023
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemicFilippo A Canale, Massimo Martino, Gaetana Porto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2019
Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34+ Cell and Platelet CountsMassimo Martino, Mercedes Gori, Tiziana Moscato, et al.
Cancers|September 13, 2025
CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern ItalyDaniele Caracciolo, Filippo Antonio Canale, Virginia Naso, et al.
Pageof 2